MoneyWorks4Me

The company witnessed a 9.48% growth in the revenue at Rs. 814.20 millions for the quarter ended March 2023 as compared to Rs. 743.73 millions during the year-ago period.The Company's Net profit for the March 2023 quarter have declined marginally to Rs. 37.35  millions as against Rs. 41.75 millions reported during the corresponding quarter ended.The company reported a good operating profit of 96.03 millions compared to 93.28 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 814.20 743.73 9.48 3415.64 3135.11 8.95 3415.64 3135.11 8.95
Other Income 0.09 -6.85 -101.31 153.96 158.41 -2.81 153.96 158.41 -2.81
PBIDT 96.03 93.28 2.95 597.40 566.35 5.48 597.40 566.35 5.48
Interest 1.13 1.70 -33.53 4.56 5.32 -14.29 4.56 5.32 -14.29
PBDT 94.90 91.58 3.63 592.84 561.03 5.67 592.84 561.03 5.67
Depreciation 22.99 23.89 -3.77 85.48 88.06 -2.93 85.48 88.06 -2.93
PBT 71.91 67.69 6.23 507.36 472.97 7.27 507.36 472.97 7.27
TAX 34.56 25.94 33.23 145.61 120.40 20.94 145.61 120.40 20.94
Deferred Tax -8.54 -6.58 29.79 -13.96 -5.74 143.21 -13.96 -5.74 143.21
PAT 37.35 41.75 -10.54 361.75 352.57 2.60 361.75 352.57 2.60
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 11.79 12.54 -5.96 17.49 18.06 -3.18 17.49 18.06 -3.18
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..